Antegrade selective cerebral perfusion and moderate hypothermia in aortic arch surgery: clinical outcomes in elderly patients† by Pacini, Davide et al.
Antegrade selective cerebral perfusion and moderate hypothermia
in aortic arch surgery: clinical outcomes in elderly patients†
Davide Pacinia, Luca Di Marcoa, Alessandro Leonea, Roberto Di Bartolomeoa, Gottfried Sodeckb,
Lars Englbergerc, Thierry Carrelc and Martin Czernyc,*
a Department of Cardiac Surgery, University of Bologna, Bologna, Italy
b Department of Cardiology, University Hospital Berne, Berne, Switzerland
c Department of Cardiovascular Surgery, University Hospital Berne, Berne, Switzerland
* Corresponding author. Freiburgstrasse 18, 3010 Berne, Switzerland. Tel: +41-31-632-2376; fax: +41-31-632-2919; e-mail: martin.czerny@insel.ch (M. Czerny).
Received 27 September 2011; received in revised form 5 December 2011; accepted 12 December 2011
Abstract
OBJECTIVES: To evaluate the outcome in elderly patients (≥75 years) undergoing elective aortic arch surgery with the aid of selective
antegrade cerebral perfusion (SACP) and moderate hypothermic circulatory arrest (HCA).
METHODS: A series of 95 patients ≥75 years (median age 77 years, median EuroSCORE 28) undergoing elective aortic arch surgery
with SACP and moderate HCA were analysed with regard to clinical outcome. Risk factors for serious adverse events (mortality, neuro-
logical injury) were determined.
RESULTS: Sixty-three patients (66%) underwent ascending aorta and hemiarch replacement, whereas 32 patients (34%) underwent
ascending aorta and total arch replacement. Isolated arch replacement was rare. Additionally, 27% of patients underwent aortic valve
replacement and 26% underwent root replacement. In-hospital mortality was 7%. Permanent neurological deﬁcits occurred in 5%, tran-
sient neurological deﬁcits occurred in 2%. Median SACP time was 24 min. Univariate analysis revealed femoral cannulation site (OR: 3.4;
CI: 1.25–9.22, P = 0.016) as well as HCA ≥40 min (OR: 4.21; CI: 1.83–12.58, P = 0.001) as predictors of serious adverse events (mortality,
neurological injury).
CONCLUSIONS: Summarizing, elective aortic arch surgery in elderly patients using SACP and moderate HCA provides excellent results
regarding mortality and postoperative neurological outcome. Prolonged HCA time and femoral cannulation were the only predictors of
serious adverse events (mortality, neurological injury).
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INTRODUCTION
Antegrade selective cerebral perfusion (ASCP) represents the
most accepted method of brain protection during aortic arch
surgery so far and its broad application has enabled a consid-
erable improvement of clinical outcome [1–4]. Hypothermic
circulatory arrest (HCA) has been used traditionally in various
forms and extents for organ protection in aortic arch surgery
[5–7]. Results in elderly patients undergoing surgery for acute
and chronic aortic arch pathology are diverging and few
reports focus on clinical outcome in elderly patients undergo-
ing elective surgery [8–10]. Consequently, there are still some
concerns about referring these patients for extensive aortic
arch surgery.
The aim of this study was to evaluate the outcome in elderly
patients (≥75 years) undergoing elective aortic arch surgery with




A series of 95 patients ≥75 years (median age 77 years, range
75–83 years) undergoing elective aortic arch surgery with SACP
and moderate HCA was operated in two different institutions
(S.Orsola-Malpighi Hospital, Bologna, Italy and University
Hospital, Berne, Switzerland) between 2005 and 2011 and was
analysed with regard to clinical outcome. The median
EuroSCORE was 28. All patients had the underlying diagnosis of
ascending aortic and/or arch aneurysm. Patient demographics
are shown in Table 1. There has been no common protocol
regarding conduction of extracorporeal circulation. Near infrared
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spectroscopy (NIRS) for cerebral monitoring was used routinely
in both centres. In order to specify the individual differences in
both centres, the conduction protocols of extracorporeal circula-
tion and SACP are described in detail for each centre below.
Conduction of extracorporeal circulation and
selective antegrade cerebral perfusion—Berne
Arterial inﬂow was by subclavian artery cannulation, direct aortic
cannulation or by the femoral artery. Standard venous drainage
was by a single two-stage cannula introduced into the right
atrium. Patients were cooled to bilateral 20°C tympanic tempera-
ture and 25°C core temperature. Vasodilators, such as nitroprus-
side, were used to achieve homogeneous cooling by reducing
peripheral vascular resistance. During rewarming, targets were
bilateral 36°C tympanic temperature and 35°C core temperature.
For cerebral perfusion, a blood temperature of 20°C was chosen
According to the individual cannulation site for bilateral SACP—
right subclavian artery or brachiocephalic trunk—ﬂows between
500 and 750 ml/min were targeted according to the anticipated
resistance of the cannulas. Most important, resistance of 50
mmHg at the level of the individual cannula was not exceeded
so as not to expose the brain to episodes of excessive pressure.
Conduction of extracorporeal circulation and
selective antegrade cerebral perfusion—Bologna
Arterial inﬂow was by right axillary artery or innominate artery,
ascending aorta or femoral artery and venous drainage was by a
single two-stage cannula via the right atrium or, in few cases,
into the femoral vein. If the axillary artery was chosen, a side
graft to the native vessel was used in each patient. Pressure mon-
itoring was achieved by means of the right radial artery pressure
line. SACP management was performed according to Dr Kazui’s
protocol [2]. Cerebral perfusion was initiated at a ﬂow rate of 10
ml/kg/min and adjusted to maintain the right radial arterial
pressure between 40 and 70 mmHg. The temperature of the
cerebral perfusate was 1–2°C less than the core temperature
(24–25°C). In the case of right axillary artery or innominate
artery cannulation, only the left common carotid artery was can-
nulated, and cerebral perfusion was obtained using the systemic
pump at a ﬂow rate of 8–10 ml/kg/min and the roller pump at a
ﬂow rate of 5 ml/kg/min. The innominate artery and the left sub-
clavian artery were occluded at the time of SACP.
Deﬁnition of clinical parameters
Clinical parameters and risk factors were deﬁned according to
EuroSCORE guidelines [11]. Mortality was deﬁned as in-hospital
death. Permanent neurological injury was deﬁned as any newly
developed sensorimotor deﬁcit persisting at the time of dis-
charge combined with a morphological correlate in cranial com-
puted tomography or magnetic resonance imaging. Transient
neurological injury was deﬁned as functional deﬁcit without any
morphological correlate having resolved at discharge.
Chronic health conditions and risk factors
Thirty-eight per cent of patients had coronary artery disease
deﬁned as any lesion of ≥50% in coronary angiography. Fourteen
per cent of patients already had previous cardiac surgery and 9% of
patients had COPD as deﬁned by EuroSCORE guidelines (Table 1).
Concomittant surgical procedures
Additionally to arch aortic surgery, 26% of patients underwent
aortic root replacement with a biological composite graft, 27%
underwent aortic valve replacement and 27% of patients under-
went additional coronary artery bypass grafting (CABG).
Table 1: Descriptive characteristics of the cohort
n overall = 95
Demographics
Age, median (IQR) 77 (76–78)
Female, n (%) 45 (47)
Chronic health conditions and risk factors
Hypertension, n (%) 82 (86)
Chronic obstructive pulmonary disease, n (%) 9 (10)
Diabetes mellitus, n (%) 8 (8)
Serum creatinine >200 mmol/l, n (%) 3 (3)
Coronary artery disease, n (%) 36 (38)
Extracardiac arteriopathy, n (%) 14 (15)
Preoperative assessment
Impaired left ventricular dysfunction, n (%) 4 (4)
Recent myocardial infarction, n (%) 2 (2)
Redo surgery, n (%) 13 (14)
Additive EUROSCORE, median (IQR) 10 (9–12)
Unless otherwise indicated, data are number (%). IQR: inter-quartile
range; classification of chronic health conditions and risk factors
according to EuroSCORE criteria.
Table 2: Description of the surgical strategy
n overall = 95
General
Composite graft placement, n (%) 25 (26)
Elephant trunk repair, n (%) 4 (4)
Frozen elephant trunk procedure, n (%) 3 (3)
Hemiarch replacement, n (%) 63 (66)
Aortic valve replacement, n (%) 26 (27)
Cannulation site
Subclavian artery, n (%) 29 (30)
Femoral artery, n (%) 22 (23)
Brachiocephalic trunk, n (%) 2 (2)
Ascending aorta, n (%) 42 (45)
Additional procedures
Coronary revascularization, n (%) 26 (27)
Mitral valve repair/replacement, n (%) 8 (8)
Perfusion time
ECC in minutes, median (IQR) 146 (112–182)
Aortic cross clamp in minutes, median (IQR) 103 (75–124)
HCA in minutes, median (IQR) 24 (16–60)
Unless otherwise indicated, data are number (%). IQR: inter-quartile
range; classification of chronic health conditions and risk factors
according to EuroSCORE criteria.
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Conventional elephant trunk procedures (4%) or frozen elephant
trunk procedures (3%) were rare (Table 2).
Cannulation sites for arterial return and HCA
times
The ascending aorta was selected for arterial return in 45% of
patients, the subclavian artery in 30% and the femoral artery in
23%. In the remaining 2%, the brachiocephalic trunk was chosen
(Table 2). ECC times, aortic cross clamp times and HCA times are
also depicted in Table 2.
Statistical methods
Continuous data are presented as the median and inter-quartile
range (range from the 25 to the 75th percentile). Discrete data
are given as counts and percentages. Comparisons of continuous
data were performed by Mann–Whitney U tests, and groups of
categorical data were compared by Fisher’s exact test. Univariate
regression analysis was performed to assess potential risk factors
for the occurrence of the composite endpoint, serious adverse
event (SAE), which was deﬁned either by in-hospital mortality,
transient and permanent neurological injury.
Results of the logistic regression model are given as the odds
ratio (OR) and the 95% conﬁdence interval (CI). A two-sided
P-value <0.05 was considered statistically signiﬁcant. All calcula-
tions were performed with SPSS 19.0 software for MacOSX.
RESULTS
Clinical outcome
In-hospital mortality was 7% (seven patients). Permanent neuro-
logical injury occurred in ﬁve patients (5%) and temporary
neurological injury was observed in two (2%). Reasons for death
were multiorgan failure as well as sequelae of already sustained
neurological injury.
Patients sustaining serious adverse events (SAE)
versus none
Patients sustaining SAE were more likely to have elevated serum
creatinine levels (22 versus 1%, P = 0.001). These patients were
also more likely to have extracardiac arteriopathy (44 versus
12%, P = 0.008). Additive EuroSCORE levels were higher (12
versus 10, P = 0.09) as was the incidence of femoral artery can-
nulation (56 versus 20%, P = 0.01). Perfusion parameters such as
ECC time (200 vs. 143 min, P = 0.008), aortic cross clamp time
(130 vs. 98 min, P = 0.02) and HCA time (50 vs. 22 min, P = 0.02)
also showed signiﬁcant differences (Table 3).
Univariate regression analysis
Univariate analysis revealed femoral cannulation site (OR: 3.4, CI:
1.25–9.22, P = 0.016) as well as HCA ≥40 min (OR: 4.21, CI: 1.83–
12.58, P = 0.001) as predictors of SAEs (mortality, neurological
injury) (Table 4).
DISCUSSION
Clinical outcome in this series was favourable with regard to
mortality and permanent neurological injury. Recent reports
suggest continuous improvement in outcome in the general
Table 3: Distribution of patients by different chronic
health conditions and in-hospital risk assessment stratified
to in-hospital outcome






Age, median (IQR) 77 (76–79) 77 (76–78) 0.83
Female sex, n (%) 3 (33) 42 (49) 0.37
Chronic health conditions and risk factors
Hypertension, n (%) 7 (78) 75 (87) 0.43
Chronic obstructive
pulmonary disease, n (%)
1 (11) 8 (9) 0.86
Diabetes mellitus, n (%) 0 (0) 8 (9) 0.34
Serum creatinine >200
mmol/l, n (%)
2 (22) 1 (1) 0.001
Coronary artery disease,
n (%)
4 (44) 32 (37) 0.67
Extracardiac arteriopathy,
n (%)




0 (0) 4 (5) 0.51
Recent myocardial
infarction, n (%)
0 (0) 2 (2) 0.64
Redo surgery, n (%) 2 (22) 11 (13) 0.43
Additive EUROSCORE,
median (IQR)




5 (56) 17 (20) 0.01
Elephant trunk procedure,
n (%)
1 (11) 3 (4) 0.28
Frozen elephant trunk
procedure, n (%)
1 (11) 2 (2) 0.15
Additional procedures,
n (%)
2 (22) 32 (37) 0.56
ECC time in minutes,
median (IQR)
200 (148–258) 143 (110–177) 0.008
Aortic cross clamp time in
minutes, median (IQR)
130 (100–163) 98 (72–123) 0.02
HCA in minutes, median
(IQR)
50 (34–89) 22 (16–56) 0.02
Unless otherwise indicated, data are number (%). IQR: inter-quartile
range; ECC: extracorporal circulation; HCA: hypothermic circulatory
arrest; SAE: serious adverse event composite endpoint, including
death, temporary and permanent neurological deficit; classification of
chronic health conditions and risk factors according to EuroSCORE
criteria.
Table 4: Predictors of serious adverse outcome—
univariate regression analysis
Risk factor OR 95% CI P-value
Femoral cannulation site 3.40 1.25–9.22 0.016
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patient population undergoing surgery for acute and chronic
aortic arch pathologies [12]. However, the percentage of elderly
patients in most reports is low and mixed with acute thoracic
aortic events [13]. As such, this report is the ﬁrst one selectively
focusing on clinical outcomes in elderly patients undergoing
elective surgery for aortic arch pathology with a similar perfu-
sional concept.
It was interesting to observe, that the percentage of patients
with concomitant coronary artery disease requiring simultaneous
treatment was higher than in most series dealing with dilatative
thoracic aortic pathology. This may well be due to the fact that
some degree of obliterative arteriopathy in elderly patients is
commonly seen. Fourteen per cent of patients already had
undergone at least one previous open heart procedure. This fact
alone combined with the results obtained underlines that redo
surgery with a procedure at the level of the aortic arch is not per
se prohibitive in these patients.
The number of concomittant surgical procedures besides
ascending and arch replacement was high. Besides CABG, aortic
valve replacement and also aortic root replacement were fre-
quently performed. As the underlying diagnosis of anuloaortic
ectasia is rare in elderly patients, many of them have the under-
lying pathology of a bicuspid aortic valve with additional ascend-
ing aortic pathology. A common indication for redo surgery after
supracoronary aortic repair is dissection or dilation especially in
the non-coronary sinus [14].
Cannulation seems by far more decisive regarding outcome
also in the elective setting than perhaps expected. It is known
that femoral cannulation has the most important impact on
physiology by ﬂow reversal and by potential embolization of
atherosclerotic debris in the thoracoabdominal aorta despite the
fact that some authors report favourable results at least in
younger patient cohorts [15]. Cannulation sites for arterial return
establishing antegrade ﬂow patterns are more physiologic, easen
SACP and do not carry the risk of cerebral embolization [16]. It
remains to the preference of the individually treating physician if
direct cannulation of the cranial ascending aorta or the right
subclavian artery is preferred. If the choice is on the ascending
aorta, care must be taken that the corresponding cerebral perfu-
sion canulla is not inserted unintentionally too deeply in the
right subclavian artery thereby compromising antegrade cerebral
perfusion. This problem will not occur if the right subclavian
artery is selected for arterial return. In any case, bihemispheric
near infrared spectroscopy is recommended irrespective of the
chosen method to reconﬁrm efﬁcacy of SACP and in order to
react if uni- or bihemispherical changes in saturation occur [17].
In order to gain better insights into the reasons for SAEs in this
series, we stratiﬁed patients into two groups—with and without
SAEs being deﬁned as a composite endpoint of mortality as well
as transient and permanent neurological injury. Patients with SAEs
were more likely to have renal failure and extracardiac arteriopa-
thy before surgery. As renal insufﬁciency seems to carry a greater
inherent risk than diabetes mellitus and is on its way to become
the most limiting factor for immediate and long-term outcome,
these ﬁndings are clear [18]. The same is true for extracardiac
arteriopathy as the presence of obliterative components of ath-
erosclerosis is a surrogate for a more severe stage of the under-
lying disease and thereby for the risk of neurological injury and
ﬁnally death. As an expected consequence, EuroSCORE levels in
patients with SAEs were also higher than in patients without SAE.
In this study, total arch replacement was not associated with
longer HCA times as antegrade systemic perfusion is
re-established immediately after accomplishment of the des-
cending aortic anastomosis which does not take longer than a
hemiarch anastomosis. The only difference is that during replan-
tation of the arch vessels antegrade cerebral perfusion is being
done selectively via catheters. Manipulation is more extensive
and thereby any risk of dislodging debris is more likely, but HCA
per se is not affected.
In univariate regression analysis, a femoral cannulation site for
arterial return and also HCA times ≥40 min were predictors of
SAEs (mortality, neurological injury). The beneﬁcial effect of sub-
clavian artery cannulation has been described previously and
seems to be the most important progress in aortic arch surgery
during the last decade [12]. A linear correlation between HCA
times and outcome is well known [19]. However, the time
needed to accomplish repair is not a surrogate of the capability
of the operating surgeon but of the extent of the underlying
disease. Consequently, especially in an elderly patient population
it remains a condition of experience and anticipation to make
the decision between a fully anatomic repair and a limited arch
repair by not fully restoring regular aortic dimensions but being
extensive enough to prevent rupture.
Limitations and strengths of the study
The main limitation of this study is its retrospective nature and
the fact that no physiologic surrogates such as the frailty index
could be applied in this retrospective setting. Even though this is
a large cohort of elderly patients undergoing aortic arch surgery,
the sample size is modest when it comes to random variability.
Residual confounding by patient-management at the operating
theatre and intensive care unit may be present. It is impossible
to control such confounders in observational, multi-centre
studies. Fortunately, serious complications are rare, thus identiﬁ-
cation of independent risk factors and therefore the justiﬁcation
of this concept to grant elderly patients access to this treatment
has to be evaluated by future research. Nevertheless, the present
study might have the potential to encourage physicians to con-
sider treatment in a patient population, which was deemed not
suitable in the majority of cases to date.
Summarizing, elective aortic arch surgery in elderly patients
using SACP and moderate HCA provides excellent results regard-
ing mortality and postoperative neurological outcome.
Prolonged HCA time and femoral cannulation were the only pre-
dictors of SAEs (mortality, neurological injury).
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APPENDIX. CONFERENCE AND DISCUSSION
Dr M. Ehrlich (Vienna, Austria): You and your co-authors report on a subject
of great interest, the outcome of ACP and moderate hypothermic circulatory
arrest in elderly patients, a population that is getting more and more challen-
ging for us surgeons.
In your series of 95 patients, the ascending aorta was selected for arterial
return in 45% of patients, the subclavian artery in only 30% and the femoral
artery in 23%. Femoral cannulation site turned out to be a predictor of
serious adverse events in univariate analysis, which brings me to my ﬁrst
question. Why was not the subclavian artery used as the arterial access site in
most of these cases which would make the implementation of ACP also
much easier? Secondly, did you use some kind of cerebral monitoring in this
series? And last, but not least, multivariate analysis revealed HCA times
greater than 40 minutes as the only independent predictor of SAE. Do you
think that in these elderly patients, when longer HCA times are anticipated,
one should cool to lower temperatures?
Dr Pacini: Regarding the ﬁrst question about femoral cannulation, as I said
before, in order to obtain antegrade perfusion and avoid retrograde perfu-
sion, we try to cannulate as much as we can, the axillary artery, the ascending
aorta, the aortic arch and the innominate artery. However, this is a retro-
spective study and the cannulation site depended on the preference of the
surgeon who did the operation.
Regarding the brain monitoring, I think that both centres involved in the
study use NIRS as the only method of monitoring cerebral perfusion. Of
course, we also have the right and the left radial artery blood pressure, but
sometimes if you cannulate the axillary artery directly, you lose the right
blood pressure, so the only monitoring on that occasion is NIRS.
And the third question was? Sorry.
Dr Ehrlich: If you’re expecting a patient to have a total arch repair, would
you -
Dr Pacini: Regarding the extension, yes. I don’t know about Berne, but in
Bologna we don’t care about the extension of the aortic arch replacement. Of
course, patients older than 75 years who have to undergo open arch surgery
are selected without associated high risk factors such as chronic renal failure or
severe chronic pulmonary disease. We limited the hybrid technique, like deb-
ranching and endografting, just to patients with very severe associated disease.
Dr M. Czerny (Berne, Switzerland): I just want to speak for the Berne side.
Actually, I think it’s a trade-off between total anatomic correction and correc-
tion implementing the most dilated parts and leaving the other parts that
aren’t at risk. I think this is the strategy and the trade-off we follow in these
cases.
Dr S. Takamoto (Tokyo, Japan): The temporary neurological dysfunction is
only 2% of the whole in these older patients. Even off-pump bypass causes
probably 10–20% temporary neurological dysfunction, someone gets dis-
orientation after the surgery. Why is it so low in your study?
Dr Pacini: We don’t know; it was strange also for us to ﬁnd a very low inci-
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